SPG21 antibody (C-Term)
Quick Overview for SPG21 antibody (C-Term) (ABIN6755545)
Target
See all SPG21 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Brand
- IHC-plus™
-
Specificity
- Human SPG21
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human SPG21 (Q9NZD8, NP_057714). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon, Marmoset, Bovine (100%), Monkey, Dog, Pig (92%), Opossum (86%), Mouse, Panda, Bat, Horse, Guinea pig (85%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Approved: IHC, IHC-P (10 μg/mL), WB (1 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- SPG21 (Spastic Paraplegia 21 (SPG21))
-
Alternative Name
- SPG21 / MAST
-
Background
-
Name/Gene ID: SPG21
Synonyms: SPG21, ACP33, Acid cluster protein 33, BM-019, Maspardin, GL010, MAST, Spastic paraplegia 21 protein -
Gene ID
- 51324
-
NCBI Accession
- NP_057714
Target
-